- published: 17 Jun 2014
- views: 3389
Fresenius SE & Co. KGaA is a European diversified health care company based in Bad Homburg, Germany. The Fresenius Group provides products and services for dialysis, hospitals as well as inpatient and outpatient medical care. In addition, the company focuses on hospital management as well as on engineering and services for medical centers and other health care facilities. The company is a component of the Euro Stoxx 50 stock market index.
Fresenius consists of four business segments, Fresenius Medical Care (a publicly traded company of which Fresenius owns 30.8%), Fresenius Helios, Fresenius Kabi and Fresenius Vamed. With activities in about 100 countries, it has more than 200,000 employees.
Another arm of Fresenius Kabi is Fresenius Kabi Oncology Plc. It produces generics of intravenous oncology products such as Paclitaxel, Irinotecan, Oxaliplatin, Gemcitabine, Cytarabine, Carboplatin, Topotecan, Docetaxel and Epirubicin.
Fresenius owns the Helios Kliniken, which has more than 100 hospitals and more than 30,000 beds, treating over 4 million patients annually. The hospital operator is the biggest provider of inpatient and outpatient care in Germany.
A company is an association or collection of individuals, whether natural persons, legal persons, or a mixture of both. Company members share a common purpose and unite in order to focus their various talents and organize their collectively available skills or resources to achieve specific, declared goals. Companies take various forms such as:
A company or association of persons can be created at law as legal person so that the company in itself can accept Limited liability for civil responsibility and taxation incurred as members perform (or fail) to discharge their duty within the publicly declared "birth certificate" or published policy.
Because companies are legal persons, they also may associate and register themselves as companies – often known as a corporate group. When the company closes it may need a "death certificate" to avoid further legal obligations.
Fresenius Medical Care
Fresenius Medical Care Company Video
Fresenius Medical Care Corporate Movie
Fresenius Medical Care Company
Fresenius Medical Care - The Renal Company
100 Years of Fresenius
Fresenius Image Film (Old Version)
How is APP - A Company of the Fresenius Kabi Group different? David Bowman
How to setup Fresenius 5008 Dialysis Machine
100 Years of Fresenius (long)
http://www.kbexchangetrust.com - Flexible Equity Investments in Single-Tenant, Net-Leased Properties. KB Exchange Trust provides real estate investors with a simplified 1031-exchange solution through DST ownership interests in net-leased properties.
Fresenius Medical Care is the world's largest provider of products and services for individuals with renal diseases of which about 2.8 million patients worldwide regularly undergo dialysis treatment. Since our company was founded 20 years ago, our patients have been our top priority. Creating a future worth living. For patients. Worldwide. Every day. That is our main goal. http://www.freseniusmedicalcare.com
http://www.kbexchangetrust.com - Flexible Equity Investments in Single-Tenant, Net-Leased Properties. KB Exchange Trust provides real estate investors with a simplified 1031-exchange solution through DST ownership interests in net-leased properties.
Over the past 100 years, Fresenius has grown from a small pharmacy lab into the global health care group you know today. This film presents the company's history in a concise, matter-of-fact form.
Fresenius is a global health care company with products and services for dialysis, the hospital and the medical care of patients at home. Around the world, Fresenius has more than 200,000 employees. A 9-minute film provides a look into Fresenius' business activities:
When it comes to generic pharmaceuticals, what makes APP different http://www.apppharma.com/ An excerpt of an interview done by Mark E Goodman with David Bowman, Vice President, Product Development in September of 2011. In this excerpt, David notes that focus on sterile products is a key differentiator. If you are using a generic sterile product in a hospital, it is likely to be from APP
Rowen setting up Dialysis machine at Luton and Dunstable Hospital
Fresenius has been working for the past century to improve the lives of seriously ill people around the world. This film tells the company's 100-year history through the stories of people who have been helped and are still being helped by Fresenius.
Annual General Meeting of Fresenius Medical Care AG & Co. KGaA on May 12, 2016, in Frankfurt, Germany. Speech of the CEO Rice Powell. Manuscript: www.freseniusmedicalcare.com/en/investors/annual-general-meeting/
Annual General Meeting of Fresenius SE & Co. KGaA on May 17, 2013, in Frankfurt, Germany. Speech of the CEO Dr. Ulf Mark Schneider (English Translation). Manuscript: http://www.fresenius.com/documents/Rede_HV_2013_e_final.pdf
Hauptversammlung der Fresenius SE & Co. KGaA am 17. Mai 2013 in Frankfurt am Main. Rede des Vorstandsvorsitzenden Dr. Ulf M. Schneider. Manuskript als PDF: http://www.fresenius.de/documents/Rede_HV_2013_d_final.pdf
Franz Fehrenbach (DE) Chairman of the Supervisory Board Robert Bosch GmbH Dr Ulf M. Schneider (DE/US), President & Chief Executive Officer Fresenius SE & Co. KGaA Topic Leader: Leonhard H. Fischer (DE) Chief Executive Officer RHJ International SA
Franz Fehrenbach (DE) Chairman of the Supervisory Board Robert Bosch GmbH Dr Ulf M. Schneider (DE/US) President & Chief Executive Officer Fresenius SE & Co. KGaA Topic Leader: Leonhard H. Fischer (DE) Chief Executive Officer RHJ International SA
Fresenius Kabi Quy Nhon Press Conference
Paul Bulcke // Congress Hall // September 15 // 11.15 am
Pressekonferenz zu den Ergebnissen im Geschäftsjahr 2013 am 25. Februar 2014 in Bad Homburg; Rede des Vorstandsvorsitzenden Dr. Ulf M. Schneider
Pressekonferenz zu den Ergebnissen im Geschäftsjahr 2014 am 25. Februar 2015 in Bad Homburg; Rede des Vorstandsvorsitzenden Dr. Ulf M. Schneider Präsentationsfolien als PDF: http://www.fresenius.de/documents/FSE_FY_2014_Ulf_Schneider_BPK_d.pdf
Dean Turney Stevens talks with Dr. Harry Jacobson, vice chancellor emeritus of Vanderbilt University Medical Center, during his recent visit to the Lipscomb University to campus to speak to College of Business students. Prior to his retirement in 2009, Dr. Harry Jacobson served as Vanderbilt University Medical Center's chief executive for 12 years during which time he oversaw the addition of the Monroe Carell Jr. Children's Hospital and development of the 100 Oaks clinic complex among other growth measures. Following his retirement, Jacobson formed early-stage investment group Tri-Star Technology Ventures and he is actively investing today in early stage health care ventures. Prior to VUMC, Jacobson, a former chief of nephrology for the U.S. Army, co-founded dialysis service company...